Curia

Curia

End-to-end drug development and manufacturing

CSV Systems Engineer III

Full-TimePosted on 9/25/2026
No salary listed
Senior
Bachelor's
Albuquerque, NM, USA
In Person

About the job

Requirements
  • Bachelor's degree in Engineering, Life Science, Information Technology, or a related field.
  • Minimum of five years of relevant experience working in a current Good Manufacturing Practice-regulated industry, specifically in computer systems validation.
  • Ability to work at elevated heights.
  • Ability to read and interpret standard operating procedures to ensure compliance.
  • Ability to maintain up-to-date training.
  • Solid knowledge of Food and Drug Administration and applicable global regulations.
  • Demonstrated proactive approach to computer system validation.
  • Ability to adjust quickly to shifting priorities and make decisions with limited information.
  • Ability to self-start, prioritize, and multitask.
  • Ability to communicate and work effectively with others and build team collaboration.
  • Excellent verbal communication and interpersonal skills to document and communicate findings and escalate critical risks to stakeholders.
  • Must pass a background check and drug screen.
  • May be required to pass occupational health screening, obtain and maintain gowning certification, obtain and maintain media qualification, and wear a respirator.
Responsibilities
  • Ensure routine tasks related to validating electronic systems and applications used in commercial drug product manufacturing are documented in compliance with company procedures and health authority regulations.
  • Generate and execute validation documents to maintain systems and software in the current validated state according to regulatory requirements.
  • Assist cross-functional teams in identifying required validation deliverables for new systems, software, and equipment or changes to existing validated systems, software, and equipment.
  • Assist cross-functional teams in completing system and equipment impact assessments and electronic record and electronic signature assessments.
  • Perform gap assessments on vendor-executed protocols to ensure compliance with current regulations.
  • Collaborate across functional areas to maintain and improve computer system validation processes.
  • Provide guidance and support during specification document generation and review, including User Requirements Specifications, Functional Specifications, Detailed Design Specifications, and Configuration Specifications.
  • Ensure required Software/System Development Lifecycle documents are available for regulatory and client audits and participate in site audits as needed.
  • Develop and execute computer system validation change records, change controls, corrective and preventive actions, and quality events.
  • Act as investigator for computer system validation deviations.
  • Support site computer system validation actions resulting from client and regulatory audits.
  • Participate as a site subject matter expert in site audits and inspections.
  • Provide guidance on quality issues affecting data integrity or system validation.
  • Maintain accurate inventory of applications, hardware, and computer systems at the Albuquerque site.
  • Ensure computer systems have up-to-date antivirus and backup software installed.
  • Update computer systems running outdated operating systems.
  • Investigate failed backups and related investigations.
  • Execute periodic reviews.
  • Provide routine project status reports, software and hardware inventory updates, standard operating procedure and template progress updates, corrective and preventive action, quality event, and change record updates, and audit observation and remediation updates.
  • Maintain up-to-date training.
  • Promote a safe and healthy work environment by identifying and addressing hazards, following safety protocols, participating in safety training, and fostering safety awareness.
  • Perform other duties as assigned.
Desired Qualifications
  • Validation experience in a current Good Manufacturing Practice-regulated quality control laboratory or sterile fill-finish operation, including developing and executing Software/System Development Lifecycle documents that meet current regulatory and industry expectations.

About the company

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.